Detalhe da pesquisa
1.
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.
Ann Intern Med
; 172(5): 306-316, 2020 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32040960
2.
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
J Virol
; 92(19)2018 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30045984
3.
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.
Blood
; 129(1): 114-125, 2017 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27760761
4.
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
PLoS Pathog
; 10(11): e1004524, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25412505
5.
Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice".
J Virol
; 93(23)2019 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31723009
6.
A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.
J Virol
; 87(3): 1322-32, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23152525
7.
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform.
NPJ Vaccines
; 9(1): 68, 2024 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38555379
8.
Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.
J Virol
; 85(6): 2878-90, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21191005
9.
COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants.
iScience
; 25(6): 104457, 2022 Jun 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35634578
10.
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates.
NPJ Vaccines
; 7(1): 7, 2022 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35064109
11.
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates.
bioRxiv
; 2021 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34545366
12.
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.
Res Sq
; 2020 Jul 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32702732
13.
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform.
Nat Commun
; 11(1): 6121, 2020 11 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33257686
14.
Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine.
bioRxiv
; 2020 Jul 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32637957
15.
Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex.
J Virol Methods
; 251: 30-37, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28989096
16.
Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults.
Viral Immunol
; 20(3): 379-88, 2007 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-17931108
17.
Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines.
Vaccine
; 28(6): 1547-57, 2010 Feb 10.
Artigo
Inglês
| MEDLINE | ID: mdl-19969118
18.
Common pigmentation disorders.
Am Fam Physician
; 79(2): 109-16, 2009 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19178061
19.
Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease.
J Infect Dis
; 197(1): 25-33, 2008 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18171281
20.
Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.
Vaccine
; 25(6): 1132-41, 2007 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-17049414